Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Yue Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7620-6078; OpenAlex author ID A5100397981. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 7

  1. FUT3-B3GNT3 interaction promotes pancreatic cancer progression and chemoresistance via NF-κB signaling mediated autophagy. Last author DOI 10.1186/s40001-025-03432-3↗
  2. Cancer cell membrane-coated upconversion nanoparticles/ZnxMn1-xS core-shell nanoparticles for targeted photodynamic and chemodynamic therapy of pancreatic canc… Last author DOI 10.1016/j.mtbio.2023.100765↗
  3. SOX9 is a critical regulator of TSPAN8-mediated metastasis in pancreatic cancer. Co-author DOI 10.1038/s41388-021-01864-9↗
  4. An NIR-activated polymeric nanoplatform with ROS- and temperature-sensitivity for combined photothermal therapy and chemotherapy of pancreatic cancer. Last author DOI 10.1039/d0bm01324b↗
  5. Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine. Co-author DOI 10.3892/ol.2019.10627↗
  6. Microarray analysis of circular RNA expression profiles associated with gemcitabine resistance in pancreatic cancer cells. First author DOI 10.3892/or.2018.6450↗
  7. Chlorin e6-Encapsulated Polyphosphoester Based Nanocarriers with Viscous Flow Core for Effective Treatment of Pancreatic Cancer. Co-author DOI 10.1021/acsami.5b05724↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fei Ding · 2 shared papers, 2018–2019 · strength 0.26
  2. Lei Jin · 1 shared paper, 2025 · strength 0.26
  3. Daohai Qian · 1 shared paper, 2025 · strength 0.26
  4. Xiaoyan Liu · 1 shared paper, 2023 · strength 0.20
  5. Chao Xu · 1 shared paper, 2018 · strength 0.14
  6. Xiang Zhan · 1 shared paper, 2020 · strength 0.13
  7. Le Ren · 1 shared paper, 2019 · strength 0.12
  8. Meng Gao · 1 shared paper, 2019 · strength 0.12
  9. Junjian Li · 1 shared paper, 2021 · strength 0.11
  10. Weiyu Ge · 1 shared paper, 2021 · strength 0.11
  11. Hongxia Wang · 1 shared paper, 2021 · strength 0.11
  12. Xianzhu Yang · 1 shared paper, 2015 · strength 0.06
  13. Fei Ding · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.